Kabir Mody

Kabir Mody is a medical professional currently serving as the Director of Clinical Development in Oncology at Moderna.12 With a background in oncology, Dr. Mody has extensive experience in cancer research and treatment, particularly focusing on gastrointestinal cancers.

Professional Background

Dr. Mody has made significant contributions to the field of oncology, specifically in the areas of:

• GI cancers, with a focus on liver and pancreas cancers
• Clinical trials (phases 1-3)
• Circulating tumor DNA (ctDNA) research1

His expertise extends to treating various types of cancer, including:

• Lymphoma
• Lung cancer
• Small intestine/colorectal cancer5

Current Role at Moderna

As of 2024, Dr. Mody is actively involved in Moderna's oncology research and development efforts. He represented Moderna at the ASCO 2024 conference, where the company showcased advancements in mRNA therapies.2 This suggests that Dr. Mody is at the forefront of innovative cancer treatments utilizing mRNA technology.

Career Path

Before joining Moderna, Dr. Mody's career included:

• Working as a Medical Oncologist in Phoenix, AZ, with 20 years of experience6
• Serving as a scientific advisor for CYDY before transitioning to his role at Moderna4

Personal Motivation

Dr. Mody's decision to pursue a career in oncology was deeply personal. He was inspired to become a doctor and specialize in cancer medicine after losing his best friend to cancer at the age of six.3 This early experience has likely shaped his dedication to advancing cancer research and treatment throughout his career.

Dr. Kabir Mody's expertise, research contributions, and current role at Moderna position him as a significant figure in the field of oncology, particularly in the development of innovative cancer therapies using mRNA technology.